Kodu・Aktsiate loetelu・Stryker Corp

Stryker Corp

Suletud

SektorTervishoid

338.87 0.97

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

332.51

Max

339.49

Põhinäitajad
By Trading Economics
Sissetulek	531M 1.3B
Müük	569M 6.6B
P/E Sektori keskmine	39.537 68.51
Aktsiakasum	3.69
Dividenditootlus	1.07
Kasumimarginaal	19.366
Töötajad	56,000
EBITDA	266M 1.6B

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+13.88% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	1.07% 2.29%
Järgmine tulemuste avaldamine	29. okt 2026
Järgmine dividendimakse kuupäev	30. okt 2026
Järgmine aktsia dividendi kuupäev (ex-date)	29. sept 2026

Turustatistika
By TradingEconomics
Turukapital	1.7B 131B
Eelmine avamishind	337.9
Eelmine sulgemishind	338.87

Uudiste sentiment

By Acuity

51%

49%

266 / 340 Pingereas Healthcare

Stryker Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. aug 2026, 20:06 UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

6. aug 2026, 20:06 UTC

Macro Event

News

Stryker Corp shares are lower as supply chain disruptions impact sales, despite meeting revenue expectations of $6.59 billion and adjusted EPS of $3.69.

5. aug 2026, 23:12 UTC

Stryker Corp shares are lower in after-market hours, reflecting unusual trading behavior and a decline in momentum since Wednesday's close. No specific news was identified.

4. aug 2026, 19:56 UTC

Stryker Corp shares are lower today, reflecting broader market trends amid a significant drop in crude oil prices since Monday's close.

3. aug 2026, 20:03 UTC

News

Stryker Corp shares are higher as Citizens lowers its price target to $400, citing strong Q2 revenue growth despite supply chain challenges.

31. juuli 2026, 23:16 UTC

Stryker Corp shares are higher in after-market trading, showing some volatility. No specific company news has been identified to explain the movement.

30. juuli 2026, 23:41 UTC

Social Media

News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

29. juuli 2026, 22:41 UTC

Stryker Corp shares are lower in after-market trading, reversing from earlier gains. The stock remains above its 20-day moving average.

28. juuli 2026, 20:51 UTC

Stryker Corp shares are lower in after-market trading, reversing earlier gains. The stock remains above its 20-day moving average.

27. juuli 2026, 19:06 UTC

Social Media

News

Correlated Moves

Stryker Corp shares reached a 13-week high today, trading higher alongside broader gains in the medical technology sector, including Intuitive Surgical's notable increase.

24. juuli 2026, 23:36 UTC

Stryker Corp shares are lower in after-market hours, with no specific news identified. Market sentiment reflects cautious optimism amid a decrease in initial jobless claims.

22. juuli 2026, 20:46 UTC

Stryker Corp. shares are higher in after-market trading, rebounding from recent declines, though still below the 20-day moving average.

21. juuli 2026, 18:16 UTC

Stryker Corp shares are lower today, following a dip that reached nearly -2%. The stock remains below its 20-day moving average.

20. juuli 2026, 20:41 UTC

Stryker Corp shares are lower in after-market hours with no specific news identified. Broader market dynamics include a decline in the US 10Y Treasury yield.

Võrdlus sarnastega

Hinnamuutus

Stryker Corp Prognoos

Hinnasiht

By TipRanks

13.88% tõus

12 kuu keskmine prognoos

Keskmine 384.25 USD 13.88%

Kõrge 455 USD

Madal 340 USD

Põhineb 18 Wall Streeti analüütiku instrumendi Stryker Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

18 ratings

Osta

Hoia

Müü

Põhineb 18 analüütiku instrumendi Stryker Corp aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

266 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.